|
 | Up a level |
Banerjee, Sube, Farina, Nicolas, Henderson, Catherine 
ORCID: 0000-0003-4340-4702, High, Juliet, Stirling, Susan, Shepstone, Lee, Fountain, Julia, Ballard, Clive, Bentham, Peter, Burns, Alistair, Fox, Chris, Francis, Paul, Howard, Robert, Knapp, Martin ORCID: 0000-0003-1427-0215, Leroi, Iracema, Livingston, Gill, Nilforooshan, Ramin, Nurock, Shirley, O’Brien, John, Price, Annabel, Thomas, Alan J., Swart, Ann Marie, Telling, Tanya and Tabet, Naji
(2023)
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial.
Health Technology Assessment, 27 (23).
1 - 108.
ISSN 1366-5278
Henderson, Catherine ORCID: 0000-0003-4340-4702, Knapp, Martin ORCID: 0000-0003-1427-0215, Stirling, Susan, Shepstone, Lee, High, Juliet, Ballard, Clive, Bentham, Peter, Burns, Alistair, Farina, Nicolas, Fox, Chris, Fountain, Julia, Francis, Paul, Howard, Robert, Leroi, Iracema, Livingston, Gill, Nilforooshan, Ramin, Nurock, Shirley, O’brien, John T., Price, Annabel, Swart, Ann Marie, Tabet, Naji, Telling, Tanya, Thomas, Alan J. and Banerjee, Sube
(2022)
Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial.
International Psychogeriatrics, 34 (10).
905 - 917.
ISSN 1041-6102
Banerjee, Sube, High, Juliet, Stirling, Susan, Shepstone, Lee, Swart, Ann Marie, Telling, Tanya, Henderson, Catherine ORCID: 0000-0003-4340-4702, Ballard, Clive, Bentham, Peter, Burns, Alistair, Farina, Nicolas, Fox, Chris, Francis, Paul, Howard, Robert, Knapp, Martin ORCID: 0000-0003-1427-0215, Leroi, Iracema, Livingston, Gill, Nilforooshan, Ramin, Nurock, Shirley, O'Brien, John, Price, Annabel, Thomas, Alan J. and Tabet, Naji
(2021)
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial.
The Lancet, 398 (10310).
1487 - 1497.
ISSN 0140-6736
